Add
MRK to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| MRK > SEC Filings for MRK > Form 8-K on 25-Jun-2009 | All Recent SEC Filings |
25-Jun-2009
Other Events, Financial Statements and Exhibits
On June 25, 2009, Merck & Co., Inc. (the "Company") closed an underwritten public offering of $1,250,000,000 aggregate principal amount of 1.875% Notes due 2011, $1,000,000,000 aggregate principal amount of 4.000% Notes due 2015, $1,250,000,000 aggregate principal amount of 5.000% Notes due 2019 and $750,000,000 aggregate principal amount of 5.850% Notes due 2039 under the Company's Registration Statement on Form S-3 (Registration No. 333-160134).
A copy of the underwriting agreement dated June 22, 2009 and entered into in connection with the notes between the Company and the underwriters named therein is attached hereto as Exhibit 1 and is incorporated herein by reference. The legal opinion related to these notes is attached hereto as Exhibit 5 and is incorporated herein by reference.
(d) Exhibits.
1 Underwriting Agreement, dated June 22, 2009, between the Company and J.P.
Morgan Securities Inc., Banc of America Securities LLC, Citigroup Global
Markets Inc. and RBS Securities Inc., as representatives of the several
underwriters named therein.
5 Opinion and Consent of Celia A. Colbert, Esq., Senior Vice President, Secretary and Assistant General Counsel of the Company.
23 Consent of Celia A. Colbert, Senior Vice President, Secretary and Assistant General Counsel of the Company (contained in Exhibit 5 to this Current Report on Form 8-K).
|
|